Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Verona Pharma Plc ADR (VRNA)

Verona Pharma Plc ADR (VRNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,121,877
  • Shares Outstanding, K 80,440
  • Annual Sales, $ 0 K
  • Annual Income, $ -54,370 K
  • EBIT $ -155 M
  • EBITDA $ -155 M
  • 60-Month Beta 0.42
  • Price/Sales 572.94
  • Price/Cash Flow N/A
  • Price/Book 23.57

Options Overview Details

View History
  • Implied Volatility 57.50% ( +2.96%)
  • Historical Volatility 47.57%
  • IV Percentile 9%
  • IV Rank 18.18%
  • IV High 224.47% on 06/10/24
  • IV Low 20.40% on 01/26/24
  • Put/Call Vol Ratio 1.75
  • Today's Volume 223
  • Volume Avg (30-Day) 1,294
  • Put/Call OI Ratio 0.46
  • Today's Open Interest 30,267
  • Open Int (30-Day) 31,488

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.36
  • Number of Estimates 4
  • High Estimate -0.32
  • Low Estimate -0.40
  • Prior Year -0.16
  • Growth Rate Est. (year over year) -125.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
31.60 +26.08%
on 11/04/24
40.13 -0.72%
on 11/12/24
+5.98 (+17.66%)
since 10/25/24
3-Month
24.50 +62.61%
on 09/05/24
40.13 -0.72%
on 11/12/24
+13.15 (+49.27%)
since 08/26/24
52-Week
11.39 +249.78%
on 05/30/24
40.13 -0.72%
on 11/12/24
+25.60 (+179.78%)
since 11/24/23

Most Recent Stories

More News
Zacks Industry Outlook Highlights Exelixis, Blueprint Medicines, CRISPR, Amicus and Verona Pharma

For Immediate ReleaseChicago, IL – October 25, 2024 – Today, Zacks Equity Research discusses Exelixis, Inc, EXEL, Blueprint Medicines BPMC, CRISPR Therapeutics CRSP, Amicus Therapeutics FOLD and Verona...

FOLD : 9.87 (+1.54%)
CRSP : 49.31 (-2.16%)
VRNA : 39.84 (+0.40%)
EXEL : 36.45 (+0.19%)
BPMC : 94.63 (+0.81%)
5 Biotech Stocks Likely to Outperform as Industry Prospects Look Bright

It has been a decent year for the biotech industry so far, buoyed by new drug approvals and positive regulatory/pipeline updates. The third-quarter earnings season has just kicked off, with most major...

FOLD : 9.87 (+1.54%)
CRSP : 49.31 (-2.16%)
VRNA : 39.84 (+0.40%)
EXEL : 36.45 (+0.19%)
BPMC : 94.63 (+0.81%)
2 Standout Biotech Stocks With 32% to 63% Upside

A strong pipeline of products could potentially transform these companies, but there are risks.

RNA : 43.80 (-2.95%)
$SPX : 6,021.63 (+0.57%)
BMY : 58.74 (-0.07%)
VRNA : 39.84 (+0.40%)
3 Healthcare Stocks That Have Outperformed Nvidia Since 2022

The healthcare sector is no slouch when it comes to top-performing growth stocks.

NVDA : 136.92 (+0.66%)
TMDX : 80.61 (+2.58%)
LLY : 789.32 (+4.55%)
VRNA : 39.84 (+0.40%)
3 Stocks That Could Be Monster Winners in 2024

Don't be surprised if these three stocks take off in the new year.

CRSP : 49.31 (-2.16%)
MDGL : 336.74 (-2.45%)
VRNA : 39.84 (+0.40%)
Lucid Is Revving Up, but This Nasdaq Stock Is Jumping Even More

Investors hoped for a rebound in the stock market, but they might have to settle for gains in these two stocks.

COMP : 7.17 (+1.41%)
$NASX : 19,175.58 (+0.63%)
LCID : 2.13 (-1.84%)
VRNA : 39.84 (+0.40%)
Small-Cap Catalyst Pharma Is Among Market's Best Price Performers

Small-cap biotech Catalyst Pharmaceuticals has been outperforming the broader market amid earnings and revenue acceleration. It joined the S&P 600 last month.

SPSM : 49.09 (-0.93%)
CPRX : 21.93 (+3.49%)
CG : 53.52 (-1.60%)
APLS : 32.63 (+2.26%)
AERI : 15.25 (+0.07%)
BLTE : 64.02 (-15.03%)
VRNA : 39.84 (+0.40%)
RVNC : 4.02 (+5.79%)
Verona Pharma plc Announces Pricing of Upsized Underwritten Public Offering

LONDON and RALEIGH, N.C., Aug. 10, 2022 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma” or the “Company”), a clinical-stage...

VRNA : 39.84 (+0.40%)
Verona Pharma plc Announces Proposed Underwritten Public Offering

LONDON and RALEIGH, N.C., Aug. 09, 2022 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma” or the “Company”), a clinical-stage...

VRNA : 39.84 (+0.40%)
Why Verona Pharma Stock Is Skyrocketing Today

The company reported overwhelmingly positive results from a late-stage study of its COPD drug candidate.

VRNA : 39.84 (+0.40%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Business Summary

Verona Pharma plc is a clinical-stage biopharmaceutical company. It researches, discovers and develops therapeutic drugs to treat respiratory diseases primarily in the United Kingdom and North America. Verona Pharma plc is based in London, the United Kingdom.

See More

Key Turning Points

3rd Resistance Point 41.09
2nd Resistance Point 40.55
1st Resistance Point 40.19
Last Price 39.84
1st Support Level 39.29
2nd Support Level 38.75
3rd Support Level 38.39

See More

52-Week High 40.13
Last Price 39.84
Fibonacci 61.8% 29.15
Fibonacci 50% 25.76
Fibonacci 38.2% 22.37
52-Week Low 11.39

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar